Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are biochemical markers used to test for liver diseases. Copy number variation (CNV) plays an important role in determining complex traits and is an emerging area in the study various diseases. We performed a genome-wide association study with liver function biomarkers AST and ALT in 407 unrelated Koreans. We assayed the genome-wide variations on an Affymetrix Genome-Wide 6.0 array, and CNVs were analyzed using HelixTree. Using single linear regression, 32 and 42 CNVs showed significance for AST and ALT, respectively (P value < 0.05). We compared CNV-based genes between the current study (KARE2; AST-140, ALT-172) and KARE1 (AST-1885, ALT-773) using NetBox. Results showed 9 genes (CIDEB, DFFA, PSMA3, PSMC5, PSMC6, PSMD12,
PSMF1
, SDC4, and SIAH1) were overlapped for AST, but no overlapped genes were found for ALT. Functional gene annotation analysis shown the
proteasome
pathway, Wnt signaling pathway, programmed cell death, and protein binding.
...
PMID:A replication study of genome-wide CNV association for hepatic biomarkers identifies nine genes associated with liver function. 2194 50
Silenced chromatin domains are restricted to specific regions. Eukaryotic chromosomes are organized into discrete domains delimited by domain boundaries. From approximately 6,000 genes in Saccharomyces cerevisiae, we previously isolated 55 boundary genes. In this study, we focus on the molecular function of one of boundary genes, YCR076C/FUB1 (function of boundary), whose function has not been clearly defined in vivo. Biochemical analysis of Fub1p revealed that it interacted with multiple subunits of the 20S
proteasome
core particle (20S CP). To further clarify the functional link between Fub1p and
proteasome
, several
proteasome
mutants were analyzed. Although only 20S CP subunits were isolated as Fub1p interactors, a genetic interaction was also observed for component of 19S regulatory particle (19S RP) suggesting involvement of Fub1p with the whole
proteasome
. We also analyzed the mechanism of boundary establishment by using
proteasome
composition factor-deficient strains. Deletion of pre9 and ump1, whose products have effects on the 20S CP, resulted in a decrease in boundary function. Domain analyses of Fub1p identified a minimum functional domain in the C terminus that was essential for boundary establishment and showed a limited sequence homology to the human
PSMF1
, which is known to inhibit
proteasome
activity. Finally, boundary assay showed that human
PSMF1
also exhibited boundary establishment activity in yeast. Our results defined the functional correlation between Fub1p and
PSMF1
.
...
PMID:Fub1p, a novel protein isolated by boundary screening, binds the proteasome complex. 2236 29
We investigated molecular features and cellular roles of PI31 (
PSMF1
) on regulation of
proteasome
function. PI31 has a C-terminal HbYX (where Hb is a hydrophobic amino acid, Y is tyrosine, and X is any amino acid) motif characteristic of several
proteasome
activators. Peptides corresponding to the PI31 C terminus also bind to and activate the 20 S
proteasome
in an HbYX-dependent manner, but intact PI31protein inhibits in vitro 20 S activity. Binding to and inhibition of the
proteasome
by PI31 are conferred by the HbYX-containing proline-rich C-terminal domain but do not require HbYX residues. Thus, multiple regions of PI31 bind independently to the
proteasome
and collectively determine effects on activity. PI31 blocks the ATP-dependent in vitro assembly of 26 S
proteasome
from 20 S
proteasome
and PA700 subcomplexes but has no effect on in vitro activity of the intact 26 S
proteasome
. To determine the physiologic significance of these in vitro effects, we assessed multiple aspects of cellular
proteasome
content and function after altering PI31 levels. We detected no change in overall cellular
proteasome
content or function when PI31 levels were either increased by moderate ectopic overexpression or decreased by RNA interference (RNAi). We also failed to identify a role of PI31 ADP-ribosylation as a mechanism for regulation of overall 26 S
proteasome
content and function, as recently proposed. Thus, despite its in vitro effects on various
proteasome
activities and its structural relationship to established
proteasome
regulators, cellular roles and mechanisms of PI31 in regulation of
proteasome
function remain unclear and require future definition.
...
PMID:Molecular and cellular roles of PI31 (PSMF1) protein in regulation of proteasome function. 2477 Apr 18
Protein turnover and quality control by the
proteasome
is of paramount importance for cell homeostasis. Dysfunction of the
proteasome
is associated with aging processes and human diseases such as neurodegeneration, cardiomyopathy, and cancer. The regulation, i.e. activation and inhibition of this fundamentally important protein degradation system, is still widely unexplored. We demonstrate here that the evolutionarily highly conserved type II triple-A ATPase VCP and the proteasome inhibitor
PSMF1
/PI31 interact directly, and antagonistically regulate proteasomal activity. Our data provide novel insights into the regulation of proteasomal activity.
...
PMID:VCP and PSMF1: Antagonistic regulators of proteasome activity. 2608 1
RAD6, an E2 ubiquitin-conjugating enzyme, is a key node for determining different DNA damage repair pathways, controlling both the error-prone and the error-free DNA damage repair pathways through differential regulation of the ubiquitination of the proliferating cell nuclear antigen (PCNA) protein. However, whether other pathways are involved in the RAD6-mediated regulation of DNA damage repair is still unclear. To deeply understand the molecular mechanisms of RAD6 in DNA damage repair, we performed a proteomic analysis and identified the changes of the protein-protein interaction (PPI) networks of RAD6 before and after X-ray irradiation. Furthermore, our study indicated that a
proteasome
-related event is likely involved in the DNA damage repair process. Moreover, we found that RAD6 promotes
proteasome
activity and nuclear translocation by enhancing the degradation of
PSMF1
and the lamin B receptor (LBR). Therefore, we provide a novel pathway that is employed by RAD6 in response to DNA damage.
...
PMID:Interactome Analysis Reveals a Novel Role for RAD6 in the Regulation of Proteasome Activity and Localization in Response to DNA Damage. 2803 28